The results of the investigation are inconclusive since the device was not returned for analysis.Based on the information received, the cause of the reported cardiac perforation, pseudoaneurysm or paralysis could not be conclusively determined.Per the ifu, cardiac perforation is a known risk during the use of this device.
|
Related manufacturer reference: 2030404-2020-00029, 9680001-2020-00023.The following was published in the international journal of cardiovascular imaging in an article titled ¿combined use of electro-anatomic mapping system and intracardiac echocardiography to achieve zero-fluoroscopy catheter ablation for treatment of paroxysmal atrial fibrillation: a single centre experience" by jan, matev¿ , et al., 11 november 2019."we included 144 consecutive patients (69% males, age 60 ± 10 years, bmi 29 ± 4,6) referred for ca of symptomatic paroxysmal af.All procedures were performed only with eam system and ice.No fluoroscopy was used.Once the transseptal access was obtained a 10 or 20-polar circular mapping catheter (afocus ii¿; abbott, abbott park, (b)(4)) and an irrigated tip ablation catheter (acticath¿, flexability¿; both abbott, abbott park, (b)(4)) were placed inside the la and the 3d eam system was initialized.One patient had cardiac tamponade immediately after double transseptal puncture, which resulted in termination of the procedure.A possible reason for tamponade could be accidental puncture of the contralateral la wall in a patient with only slightly enlarged la and a floppy interatrial septum.Two patients had a pseudoaneurysm of the right femoral artery that required surgical intervention.Four patients had a peri-procedural pericardial effusion, which resolved spontaneously without any treatment.All four pericardial effusions manifested shortly after the procedure, which implies they were not a consequence of transseptal puncture, but rather of transmural rf lesions.One patient had prolonged paresis of the right diaphragm, which eventually resolved after 6 months.".
|